非编码RNA对三阴性乳腺癌STAT3/CSE/H2S轴的直接和间接调控:MALAT-1 lncRNA、miR-486-5p 和 miR-30a-5p

IF 2.9 4区 医学 Q2 PATHOLOGY
Rana A. Youness , Nour Khater , Aisha El-Khouly , Heba Nafea , Tamer Manie , Danira Habashy , Mohamed Z. Gad
{"title":"非编码RNA对三阴性乳腺癌STAT3/CSE/H2S轴的直接和间接调控:MALAT-1 lncRNA、miR-486-5p 和 miR-30a-5p","authors":"Rana A. Youness ,&nbsp;Nour Khater ,&nbsp;Aisha El-Khouly ,&nbsp;Heba Nafea ,&nbsp;Tamer Manie ,&nbsp;Danira Habashy ,&nbsp;Mohamed Z. Gad","doi":"10.1016/j.prp.2024.155729","DOIUrl":null,"url":null,"abstract":"<div><div>Recently, our research group reported an upregulated expression profile of cystathionine γ-lyase (CSE) and cystathionine β-synthase (CBS), key enzymes involved in hydrogen sulfide (H<sub>2</sub>S) production, in triple-negative breast cancer (TNBC) patients. However, the regulatory mechanisms underlying such altered expression patterns are not yet fully understood. In this study, we focused on the role of the STAT3/CSE/H<sub>2</sub>S axis and the potential involvement of non-coding RNAs (ncRNAs), including long and short ncRNAs, in modulating this pivotal pathway. The results revealed that STAT3 was upregulated and positively correlated with CSE expression in BC patients. Additionally, the lncRNA MALAT-1 was found to regulate STAT3 expression, indirectly influencing CSE levels. Furthermore, we explored the interplay between the IGF-1R as a gatekeeper for JAK/STAT pathway and accordingly its impact on the STAT3/CSE/H<sub>2</sub>S axis in TNBC cell lines. Our results demonstrated that miR-486–5p, a tumor suppressor miRNA, directly targets IGF-1R, leading to the downstream suppression of STAT3 and CSE in MDA-MB-231 cells. To identify a direct upstream repressor of CSE and CBS, we conducted an <em>in silico</em> analysis and identified miR-30a-5p as a promising candidate. When ectopically expressed, miR-30a-5p was downregulated in BC tissues and effectively suppressed CSE and CBS expression. In conclusion, this study revealed novel regulatory mechanisms involved in CSE and CBS expression in TNBC patients and cell lines. Abolishing H<sub>2</sub>S-synthesizing machinery, particularly via miR-30a-5p, may represent a promising therapeutic strategy for TNBC patients.</div></div>","PeriodicalId":19916,"journal":{"name":"Pathology, research and practice","volume":"265 ","pages":"Article 155729"},"PeriodicalIF":2.9000,"publicationDate":"2024-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Direct and indirect modulation of STAT3/CSE/H2S axis in triple negative breast cancer by non-coding RNAs: MALAT-1 lncRNA, miR-486–5p and miR-30a-5p\",\"authors\":\"Rana A. Youness ,&nbsp;Nour Khater ,&nbsp;Aisha El-Khouly ,&nbsp;Heba Nafea ,&nbsp;Tamer Manie ,&nbsp;Danira Habashy ,&nbsp;Mohamed Z. Gad\",\"doi\":\"10.1016/j.prp.2024.155729\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Recently, our research group reported an upregulated expression profile of cystathionine γ-lyase (CSE) and cystathionine β-synthase (CBS), key enzymes involved in hydrogen sulfide (H<sub>2</sub>S) production, in triple-negative breast cancer (TNBC) patients. However, the regulatory mechanisms underlying such altered expression patterns are not yet fully understood. In this study, we focused on the role of the STAT3/CSE/H<sub>2</sub>S axis and the potential involvement of non-coding RNAs (ncRNAs), including long and short ncRNAs, in modulating this pivotal pathway. The results revealed that STAT3 was upregulated and positively correlated with CSE expression in BC patients. Additionally, the lncRNA MALAT-1 was found to regulate STAT3 expression, indirectly influencing CSE levels. Furthermore, we explored the interplay between the IGF-1R as a gatekeeper for JAK/STAT pathway and accordingly its impact on the STAT3/CSE/H<sub>2</sub>S axis in TNBC cell lines. Our results demonstrated that miR-486–5p, a tumor suppressor miRNA, directly targets IGF-1R, leading to the downstream suppression of STAT3 and CSE in MDA-MB-231 cells. To identify a direct upstream repressor of CSE and CBS, we conducted an <em>in silico</em> analysis and identified miR-30a-5p as a promising candidate. When ectopically expressed, miR-30a-5p was downregulated in BC tissues and effectively suppressed CSE and CBS expression. In conclusion, this study revealed novel regulatory mechanisms involved in CSE and CBS expression in TNBC patients and cell lines. Abolishing H<sub>2</sub>S-synthesizing machinery, particularly via miR-30a-5p, may represent a promising therapeutic strategy for TNBC patients.</div></div>\",\"PeriodicalId\":19916,\"journal\":{\"name\":\"Pathology, research and practice\",\"volume\":\"265 \",\"pages\":\"Article 155729\"},\"PeriodicalIF\":2.9000,\"publicationDate\":\"2024-11-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pathology, research and practice\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S034403382400640X\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"PATHOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pathology, research and practice","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S034403382400640X","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PATHOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

最近,我们的研究小组报告了三阴性乳腺癌(TNBC)患者体内胱硫醚γ-赖氨酸酶(CSE)和胱硫醚β-合成酶(CBS)表达上调的情况,这两种酶是参与硫化氢(H2S)生成的关键酶。然而,这种表达模式改变背后的调控机制尚未完全明了。在这项研究中,我们重点研究了 STAT3/CSE/H2S 轴的作用以及非编码 RNA(ncRNA)(包括长短 ncRNA)在调节这一关键通路中的潜在参与。结果发现,STAT3在BC患者中上调,并与CSE的表达呈正相关。此外,研究还发现lncRNA MALAT-1可调控STAT3的表达,间接影响CSE水平。此外,我们还探讨了IGF-1R作为JAK/STAT通路的看门人之间的相互作用,并据此探讨了它对TNBC细胞系中STAT3/CSE/H2S轴的影响。我们的研究结果表明,肿瘤抑制miRNA miR-486-5p直接靶向IGF-1R,导致MDA-MB-231细胞中STAT3和CSE受到下游抑制。为了确定CSE和CBS的直接上游抑制因子,我们进行了一项硅学分析,发现miR-30a-5p是一个很有希望的候选因子。当异位表达时,miR-30a-5p 在 BC 组织中下调,并有效抑制了 CSE 和 CBS 的表达。总之,这项研究揭示了TNBC患者和细胞系中CSE和CBS表达的新调控机制。废除H2S合成机制,特别是通过miR-30a-5p,可能是治疗TNBC患者的一种有前途的策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Direct and indirect modulation of STAT3/CSE/H2S axis in triple negative breast cancer by non-coding RNAs: MALAT-1 lncRNA, miR-486–5p and miR-30a-5p
Recently, our research group reported an upregulated expression profile of cystathionine γ-lyase (CSE) and cystathionine β-synthase (CBS), key enzymes involved in hydrogen sulfide (H2S) production, in triple-negative breast cancer (TNBC) patients. However, the regulatory mechanisms underlying such altered expression patterns are not yet fully understood. In this study, we focused on the role of the STAT3/CSE/H2S axis and the potential involvement of non-coding RNAs (ncRNAs), including long and short ncRNAs, in modulating this pivotal pathway. The results revealed that STAT3 was upregulated and positively correlated with CSE expression in BC patients. Additionally, the lncRNA MALAT-1 was found to regulate STAT3 expression, indirectly influencing CSE levels. Furthermore, we explored the interplay between the IGF-1R as a gatekeeper for JAK/STAT pathway and accordingly its impact on the STAT3/CSE/H2S axis in TNBC cell lines. Our results demonstrated that miR-486–5p, a tumor suppressor miRNA, directly targets IGF-1R, leading to the downstream suppression of STAT3 and CSE in MDA-MB-231 cells. To identify a direct upstream repressor of CSE and CBS, we conducted an in silico analysis and identified miR-30a-5p as a promising candidate. When ectopically expressed, miR-30a-5p was downregulated in BC tissues and effectively suppressed CSE and CBS expression. In conclusion, this study revealed novel regulatory mechanisms involved in CSE and CBS expression in TNBC patients and cell lines. Abolishing H2S-synthesizing machinery, particularly via miR-30a-5p, may represent a promising therapeutic strategy for TNBC patients.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
5.00
自引率
3.60%
发文量
405
审稿时长
24 days
期刊介绍: Pathology, Research and Practice provides accessible coverage of the most recent developments across the entire field of pathology: Reviews focus on recent progress in pathology, while Comments look at interesting current problems and at hypotheses for future developments in pathology. Original Papers present novel findings on all aspects of general, anatomic and molecular pathology. Rapid Communications inform readers on preliminary findings that may be relevant for further studies and need to be communicated quickly. Teaching Cases look at new aspects or special diagnostic problems of diseases and at case reports relevant for the pathologist''s practice.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信